KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Regeneron Pharmaceuticals (REGN) over the last 3 years, with Q4 2025 value amounting to -$300000.0.

  • Regeneron Pharmaceuticals' Exchange Rate Effect rose 5714.29% to -$300000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $300000.0, marking a year-over-year increase of 14285.71%. This contributed to the annual value of $300000.0 for FY2025, which is 14285.71% up from last year.
  • As of Q4 2025, Regeneron Pharmaceuticals' Exchange Rate Effect stood at -$300000.0, which was up 5714.29% from -$400000.0 recorded in Q3 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Exchange Rate Effect peaked at $800000.0 during Q3 2024, and registered a low of -$700000.0 during Q4 2024.
  • Its 3-year average for Exchange Rate Effect is -$72727.3, with a median of -$300000.0 in 2024.
  • Data for Regeneron Pharmaceuticals' Exchange Rate Effect shows a peak YoY increase of 50000.0% (in 2024) and a maximum YoY decrease of 45000.0% (in 2024) over the last 5 years.
  • Regeneron Pharmaceuticals' Exchange Rate Effect (Quarter) stood at $200000.0 in 2023, then tumbled by 450.0% to -$700000.0 in 2024, then skyrocketed by 57.14% to -$300000.0 in 2025.
  • Its Exchange Rate Effect stands at -$300000.0 for Q4 2025, versus -$400000.0 for Q3 2025 and $400000.0 for Q2 2025.